Insulet Presents its Argument in Patent Trial against Roche
shot by IP News Shots / 7:28 pm on 12 May, 2021
Insulet Corp. presented its argument as a patent infringement trial against Roche Holding AG began. The medical device maker asserted that Roche rushed to manufacture their tubeless insulin pumps before Insulet’s patent expired so that they could be ahead of their competitors.
Read More at: https://www.law360.com/ip/articles/1383433
Industry: Healthcare Equipment & Supplies, Healthcare Technology
Baxter’s En Banc Appeal against CAFC’s Affirmation of PTAB Rulings Declined
shot by IP News Shots / 10:40 am on 12 May, 2021
An en banc appeal by Baxter Corp. Englewood against an affirmation by the US Court of Appeals for the Federal Circuit (CAFC) of a Patent Trial and Appeal Board (PTAB) decision, has been declined. The appellant wanted a full federal review of the board’s rulings which invalidated two of their medicine dosing patents on challenge by Becton Dickinson & Co. Baxter had argued that the PTAB violated the Administrative Procedure Act in invalidating the patents as it relied on invalidity arguments not presented by Becton in its petitions for an inter partes review.
Read More at: https://www.law360.com/ip/articles/1383060/full-fed-circ-won-t-review-becton-s-wins-on-drug-dosing-ip
Industry: Healthcare Equipment & Supplies, Pharmaceuticals
Select Myriad Autoimmune Assets and IP to be Sold to Labcorp
shot by IP News Shots / 4:57 pm on 04 May, 2021
Myriad Genetics, Inc. has announced the signing of an agreement with Laboratory Corporation of America Holdings (Labcorp) to sell select assets and intellectual property (IP) of Myriad Autoimmune. The sales deal includes Vectra, a test developed to understand rheumatoid arthritis disease activity in patients.
Industry: Biotechnology, Healthcare Equipment & Supplies
District Court Judge Seeks Better Clarity Over Heart Monitor Patent Validity
shot by IP News Shots / 4:49 pm on 03 May, 2021
The US District Court for the District of Massachusetts has told that it is too early to decide on a heart monitor patent to deem it invalid under Alice. The licensor of the patent CardioNet LLC and the patent owner Braemar Manufacturing LLC have asserted that the patent has already been upheld by the US Court of Appeals for the Federal Circuit. On the other hand, patent challenger InfoBionic Inc. asserts invalidity of the patent. However, the court has rejected an appeal by either parties for a decision and asked to set up a schedule where the question can be briefed for better clarity on patent validity.
Read More at: https://www.law360.com/articles/1380528/mass-judge-says-heart-monitor-patent-validity-isn-t-clear-yet
Industry: Healthcare Equipment & Supplies
USPTO Rejects Tobra’s Invalidity Argument against Hensler’s Patent
shot by IP News Shots / 5:36 pm on 27 April, 2021
Tobra Medical Inc.’s patent validity challenge against Hensler Surgical Products, LLC has been rejected by the US Patent and Trademark Office (USPTO). Tobra’s loss at the patent office has opened up the way for Hensler’s patent infringement litigation, through which the former was accused of infringing on Hensler’s patent with the Tobra Medical Bone Basket. The patent infringement litigation against Tobra is filed with the US District Court for the Eastern District of North Carolina.
Industry: Healthcare Equipment & Supplies
J&J Chief Patent Attorney Shares Views on IP Waiver for COVID-19 Vaccines
shot by IP News Shots / 5:19 pm on 23 April, 2021
The chief patent attorney of Johnson & Johnson expressed his views on the petition for intellectual property (IP) waiver for COVID-19 vaccines, at a webinar. The Chief said that waiving the IP rights for the vaccines would result in safety issues which can be avoided by voluntary licensing. He went on to state that IP owning companies can opt to provide licenses to manufacturers that are capable of hosting the right infrastructure for the process which is not possible when the IP rights are waived and everyone is allowed to manufacture the vaccines.
Read More at: https://www.law360.com/articles/1375715/j-j-s-chief-patent-atty-says-covid-ip-waiver-won-t-work
Industry: Healthcare Equipment & Supplies, Pharmaceuticals